Haemato AG (HM:HAEK) — Market Cap & Net Worth

$64.92 Million USD · €55.53 Million EUR · Rank #20970

Market Cap & Net Worth: Haemato AG (HAEK)

Haemato AG (HM:HAEK) has a market capitalization of $64.92 Million (€55.53 Million) as of May 29, 2026. Listed on the HM stock exchange, this Germany-based company holds position #20970 globally and #1894 in its home market, demonstrating a 0.78% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Haemato AG's stock price €13.00 by its total outstanding shares 5229307 (5.23 Million). Analyse Haemato AG cash conversion from operations to see how efficiently the company converts income to cash.

Haemato AG Market Cap History: 2025 to 2026

Haemato AG's market capitalization history from 2025 to 2026. Data shows growth from $54.41 Million to $79.48 Million (0.00% CAGR).

Haemato AG Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Haemato AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of HAEK by Market Capitalization

Companies near Haemato AG in the global market cap rankings as of May 29, 2026.

Key companies related to Haemato AG by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.54 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #569 globally with a market cap of $47.02 Billion USD ( CN¥321.31 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#503	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#555	GALDERMA GROUP AG	NYSE:GALDY	$48.54 Billion	$41.39
#569	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$47.02 Billion	CN¥50.37
#618	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.60

Haemato AG Historical Marketcap From 2025 to 2026

Between 2025 and today, Haemato AG's market cap moved from $54.41 Million to $ 79.48 Million, with a yearly change of 0.00%.

Year	Market Cap	Change (%)
2026	€79.48 Million	+46.07%
2025	€54.41 Million	--

End of Day Market Cap According to Different Sources

On May 28th, 2026 the market cap of Haemato AG was reported to be:

Source	Market Cap
Yahoo Finance	$64.92 Million USD
MoneyControl	$64.92 Million USD
MarketWatch	$64.92 Million USD
marketcap.company	$64.92 Million USD
Reuters	$64.92 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Haemato AG

HM:HAEK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$79.48 Million

€67.98 Million EUR

Market Cap Rank

#20970 Global

#1894 in Germany

Share Price

€13.00

Change (1 day)

+0.78%

52-Week Range

€8.25 - €13.00

All Time High

€13.00